Recent developments in prescription opioidrelated dispensing and harm indicators in Ontario, Canada

Pain Physician

Volumn 18, Issue 4, 2015, Pages E659-E662

  Fischer, Benedikt ^a,b,c,d   Jones, Wayne ^c   Murphy, Yoko ^a,c   Ialomiteanu, Anca ^a   Rehm, Jürgen ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; FENTANYL; HYDROMORPHONE; OPIATE; OXYCODONE;

ARTICLE; CANADA; DRUG FORMULATION; DRUG USE; HAZARD RATIO; HUMAN; MORBIDITY; MORTALITY; PHYSICIAN; PRESCRIPTION; PRESCRIPTION DRUG DIVERSION;

EID: 84938064740     PISSN: 15333159     EISSN: 21501149     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician 2012; 15:ES191-ES203.
2. Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005–2010. Pharmacoepidemiol Drug Saf 2011; 20:1269-1277.
3. Fischer B, Jones W, Rehm J. Trends and changes in prescription opioid analge sic dispensing in Canada 2005-2012: An update with a focus on recent interventions. BMC Health Serv Res 2014;1 4:90.
4. Drug and Alcohol Treatment Information System (DATIS). Substance Abuse Statistical Tables: Fiscal Year 2007/2008 to Fiscal Year 2012/2013. 2013.
5. Office of the Chief Coroner (Ontario). Number of Opioid Related Deaths by Drug 2002–2013. 2014.
6. Ialomiteanu A, Adlaf EM, Hamilton H, Mann RE. 2011 CAMH Monitor eReport: Addiction and Mental Health Indicators Among Ontario Adults 1977-2011. 2012; CAMH Research Document Series No. 35.
7. IMS Brogan. Canadian Compuscript Data on Prescription Opioid Dispensing from Canadian Retail Pharmacies 2005 – 2013 (data update). November 27, 2014.
8. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009; 181:891-896.
9. Fischer B, Ialomiteanu A, Kurdyak P, Mann RE, Rehm J. Reductions in nonmedical prescription opioid use among adults in Ontario, Canada: Are recent policy interventions working? Subst Abuse Treat Prev Policy 2013; 8:4.
10. Whelan E, Asbridge M, Haydt S. Representations of OxyContin in North American newspapers and medical journals. Pain Res Manage 2011; 16:252-258.
11. Borwein A, Kephart G, Whelan E, Asbridge M. Prescribing practices amid the OxyContin crisis: Examining the effect of print media coverage on opioid prescribing among physicians. J Pain 2013; 14:1686-1693.
12. Wenghofer EF, Wilson L, Kahan M, Sheehan C, Srivastava A, Rubin A, Brathwaite, J. Survey of Ontario primary care physicians’ experiences with opioid prescribing. Can Fam Physician 2011; 57:324-332.
13. Dasgupta N, Mandl KD, Brownstein JS. Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality. PloS One 2009; 4:e7758.
14. Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, Grey T, Johnson EM, Lee LK, Passik SD, Peppin J, Porucznik CA, Ray A, Schnoll SH, Stieg RL, Wakeland W. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011; 12:S26-S35.
15. Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, Harvey W, Loring LD. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012; 13:87-95.
16. Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: A population-based study in Ontario, Canada. PLoS One 2013; 8:e60600.
17. Fishman SM. Commentary in response to Paulozzi et al: Prescription drug abuse and safe pain management. Pharmacoepidemiol Drug Saf 2006; 15:628-631.
18. Paulozzi L, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011; 12:747-754.